Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223168 · ClinicalTrials.gov registry record · NA
Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology
A NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03223168: Completed NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology, sponsored by University of Michigan.
NCT03223168 is a NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology that has completed, run by University of Michigan. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03223168, a NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
Primary Outcome
Pulmonary artery wedge pressure will be measured in millimeters of mercury (mmHg) at baseline and completion of noninvasive negative pressure ventilation.
Conditions Studied
Interventions
- DEVICE Hayek RTX ventilator
Study Locations (1)
Michigan
- University of MIchigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2018-07-19 |
| Phase | NA |
What the finished NCT03223168 record still lists
NCT03223168 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Pediatric Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Hayek RTX ventilator is the first listed.
NCT03223168 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03223168 about?
NCT03223168 is a clinical study titled "Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology". The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
What is the current status of trial NCT03223168?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-07-19. Estimated completion is 2018-07-19.
What conditions does trial NCT03223168 study?
This clinical trial studies the following conditions: Pediatric Congenital Heart Disease, Failing Fontan Physiology.
What interventions are being tested in trial NCT03223168?
The interventions under investigation include: Hayek RTX ventilator (DEVICE).
Who is sponsoring clinical trial NCT03223168?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03223168 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03223168's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI